Loading...
XSHE300239
Market cap441mUSD
Jan 09, Last price  
5.45CNY
1D
-2.50%
1Q
5.42%
Jan 2017
-32.55%
IPO
17.06%
Name

Baotou Dongbao Bio-Tech Co Ltd

Chart & Performance

D1W1MN
XSHE:300239 chart
P/E
26.99
P/S
3.32
EPS
0.20
Div Yield, %
0.66%
Shrs. gr., 5y
5.83%
Rev. gr., 5y
16.57%
Revenues
975m
+3.30%
119,165,801155,028,799192,366,900207,548,143255,573,324382,109,453251,053,920291,916,097316,593,978356,244,410452,748,251491,819,372448,827,791612,165,671943,396,998974,512,217
Net income
120m
+9.55%
11,893,85111,367,56021,624,48924,671,45435,383,45042,641,7244,888,0905,889,58419,226,95722,416,63733,977,15735,607,13818,450,30136,484,130109,437,321119,885,372
CFO
199m
+2.09%
013,827,99411,883,76524,215,0175,456,6249,083,277045,574,10740,537,614060,001,285-41,633,06863,129,60351,501,086195,317,536199,394,285
Dividend
May 31, 20240.022 CNY/sh
Earnings
May 14, 2025

Profile

Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, production, and sale of gelatin and collagen products in the People's Republic of China and internationally. It offers food additive and pharmaceutical gelatin, as well as collagen peptide. The company was founded in 1997 and is based in Baotou, the People's Republic of China.
URL
http://www.dongbaoshengwu.com/
IPO date
Jul 06, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
974,512
3.30%
943,397
54.11%
Cost of revenue
789,005
763,912
Unusual Expense (Income)
NOPBT
185,508
179,485
NOPBT Margin
19.04%
19.03%
Operating Taxes
17,121
16,211
Tax Rate
9.23%
9.03%
NOPAT
168,386
163,274
Net income
119,885
9.55%
109,437
199.96%
Dividends
(21,283)
(3,562)
Dividend yield
0.56%
0.08%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,884
43,088
Long-term debt
462,823
152,000
Deferred revenue
45,157
48,667
Other long-term liabilities
10,000
10,000
Net debt
(304,432)
(228,381)
Cash flow
Cash from operating activities
199,394
195,318
CAPEX
(132,242)
Cash from investing activities
(130,411)
Cash from financing activities
305,869
175,083
FCF
94,464
12,333
Balance
Cash
748,691
356,112
Long term investments
24,447
67,356
Excess cash
724,413
376,299
Stockholders' equity
1,173,544
1,121,295
Invested Capital
1,692,644
1,618,299
ROIC
10.17%
10.63%
ROCE
7.58%
8.89%
EV
Common stock shares outstanding
611,972
593,603
Price
6.23
-16.93%
7.50
6.38%
Market cap
3,812,587
-14.36%
4,452,022
11.99%
EV
3,743,287
4,450,987
EBITDA
267,472
265,000
EV/EBITDA
14.00
16.80
Interest
5,373
7,628
Interest/NOPBT
2.90%
4.25%